Data / Form D filings / SELEXYS PHARMACEUTICALS CORP
SELEXYS PHARMACEUTICALS CORP: Form D filings
SELEXYS PHARMACEUTICALS CORP, a biotechnology company in Oklahoma City, OK, filed 6 Form D notices with the SEC between 2009 and 2015. The latest, on February 23, 2015, reports $43.2 million sold of a $43.2 million offering to 57 investors.
Find out what SELEXYS PHARMACEUTICALS CORP does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 840 RESEARCH PARKWAY, SUITE 516, Oklahoma City, OK, 73104
- Phone
- (405) 319-8198
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- No Revenues
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1442824
The full lists. Form D filings in Oklahoma: 227 rows, $11.35, or the new rows each week for $19 a month. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Feb 23, 2015 | Amendment | $43,196,831 | $43,196,831 | $0 | 57 | Sep 17, 2012 | sec.gov |
| Oct 2, 2012 | New notice | $45,659,537 | $34,459,532 | $11,200,005 | 57 | Sep 17, 2012 | sec.gov |
| Nov 4, 2011 | Amendment | $5,000,000 | $5,000,000 | $0 | 34 | Nov 21, 2010 | sec.gov |
| Apr 20, 2011 | Amendment | $5,000,000 | $2,800,000 | $2,200,000 | 25 | Nov 21, 2010 | sec.gov |
| Dec 1, 2010 | New notice | $5,000,000 | $200,000 | $4,800,000 | 2 | Nov 21, 2010 | sec.gov |
| Jul 2, 2009 | Amendment | $3,435,000 | $3,435,000 | $0 | 31 | Aug 11, 2008 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| David Falconer | Executive Officer | |
| Philip Jones, M.D. | Director | |
| David Keiser | Director | |
| Richard Alvarez | Executive Officer | |
| Todd Foley | Director | |
| Russell Rother | Executive Officer | |
| Rodger McEver, M.D. | Director | |
| Scott Rollins, Ph.D. | Executive Officer, Director |
Other biotechnology companies in Oklahoma that filed recently
- Endless Corp $100,000 · Aug 19, 2026
Every Form D from the week of Feb 23, 2015 · All recent filings in Oklahoma · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what SELEXYS PHARMACEUTICALS CORP reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.